IP Library Granted Patent US 8,642,785
Granted Patent B2
US 8,642,785 · App. 12/520,924 · Granted Feb 4, 2014

Photolabile dinitroindolinyl based compounds

Inventor: Graham Ellis-Davies (Philadelphia, PA)
Assignee: Philadelphia Health & Education Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,785
App. No.
12/520,924
Granted
Feb 4, 2014
Kind
B2
Abstract

The present invention relates to photolabile or photoreleasable compounds including a caging moiety linked to an effector moiety, wherein the compounds are capable of releasing the effector moiety on irradiation, typically by flash irradiation with UV light. These compounds are particularly suitable for focal 2-photon uncaging The photoreleasable compounds can be used to deliver effector moieties such as carboxylic acids, preferably, neuroactive amino acids to sites where their activity is required. In preferred embodiments of the invention, the caging moiety is based on 4-carboxymethoxy-5,7-dinitroinlinyl and derivatives thereof.

Claims (29)

1. A photolabile compound depicted by the formula:

wherein:

R 1 is O(CH 2 ) n CO 2 H, O(CH 2 ) n OPO(OH) 2 , O(CH 2 ) n OSO 2 (OH), O(CH 2 ) n C(O)NR 3 , (CH 2 ) n CO 2 H, (CH 2 ) n OPO(OH) 2 , (CH 2 ) n OSO 2 (OH), (CH 2 ) n C(O)NR 3 , C 1-10 alkyl or substituted alkyl, O(CH 2 ) n M, N(COZ)(CH 2 ) m Y, or N[(CH 2 ) m Q][(CH 2 ) n Y],

R 2 is H, (CH 2 ) n CO 2 H, (CH 2 ) n OPO(OH) 2 , (CH 2 ) n OSO 2 (OH), (CH 2 ) n C(O)NR 3 or (CH) n N(R 3 ) 2 ,

R 3 is H, Me or Et,

n and m are independently from 1 to 10,

Q and Y are independently selected from H, CO 2 H or salts thereof, or OPO 3 2− ,

M is selected from CO 2 H or salts thereof, or OPO 3 2− ,

Z is H, C 1-10 alkyl or substituted alkyl, and

X is a non-carboxyl portion of a carboxylic acid.

2. The photolabile compound of claim 1 , wherein the carboxylic acid is a neuroactive amino acid.

3. The photolabile compound of claim 2 , wherein the neuroactive amino acid is at least one of L-glutamate, gamma-aminobutyric acid, D-aspartate and glycine.

4. A photolabile compound represented by one of the following formulas:

5. A photolabile compound selected from the group consisting of:

(a)

5-CNI-glu

Formula (V);

(b)

CNI-glu

Formula (VI);

(c)

5-CNI-GABA

Formula (VII);

(d)

CNI-GABA

Formula (VIII); and

(e)

CNI-GABA

Formula (IX).

Assignments (3)
MERGER Recorded Jan 7, 2015
From: PHILADELPHIA HEALTH & EDUCATION CORPORATION
To: DREXEL UNIVERSITY
Reel/Frame 034650/0341 →
CONFIRMATORY LICENSE Recorded Apr 9, 2013
From: DREXEL UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030175/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2009
From: ELLIS-DAVIES, GRAHAM
To: PHILADELPHIA HEALTH & EDUCATION CORPORATION, D/B/A DREXEL UNIVERSITY COLLEGE OF MEDICINE
Reel/Frame 022863/0250 →
Continuity (2)
Provisional Application 60887530 · Jan 31, 2007
Related Publication 20100096252A1 · Apr 22, 2010